Composition BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of BPC-157 and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of two co-formulated peptides Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions Documentation Lot-specific COA Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
The goal is to keep the deficiency from coming back
Rather than waiting for symptoms of cognitive decline to appear and then attempting to reverse established damage, some researchers advocate for early intervention with neuroprotective peptides in at-risk populations
Dihexa shows cognitive enhancement at picomolar concentrations, making it approximately ten million times more potent than brain-derived neurotrophic factor in some synaptogenesis assays
The lowered absorption rate and increased frequency attributed to oral supplements can cause the overall treatment process to be slower than that of B12 injections
Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, has observed that restoring spinal alignment and nerve glide reduces ongoing irritation